Foundation capital

The Hevolution Foundation Announces New Geroscience Awards

Hevolution is committing $8.5 million to support junior researchers through a multi-year grant program with the American Federation for Research on Aging.

Hevolution Foundation, a nonprofit organization that provides grants and seed investments to encourage health science research and entrepreneurship, and the American Federation for Research in Aging (AFAR) announced today an international research grants program to enable early career researchers to conduct research into therapies and treatments that broaden health.

Felipe Sierra, PhD, Scientific Director, Evolution Foundation

Longevity.Technology: Founded on the belief that every person has the right to live a longer and healthier life, the Hevolution Foundation’s mission is to stimulate efforts to extend the healthy human lifespan and understand the aging process. By focusing on aging as a treatable process, the Foundation aims to increase the number of aging-related treatments on the market, reduce the timeline for drug development, and increase accessibility to therapies that extend lifespan. of life.

A Riyadh-based non-profit organization with an annual budget of up to $1 billion, the Hevolution Foundation plans to open centers in North America and other global locations to support a global ecosystem of cutting-edge talent to to propel research on aging and geroscience forward. and achieve medical breakthroughs to help humanity live healthier, longer lives.

Representing the Hevolution Foundation’s first capital deployment in aging research, the Hevolution/AFAR Awards for New Investigators in Biology of Aging and Geroscience Research will provide up to 18 three-year fellowships of US$375,000 each. The awards will support research projects in the basic biology of aging and/or geroscience, a research paradigm focused on the biology of aging and the biology of age-related diseases. Junior researchers from all over the world are welcome to apply.

“The goal of our grant programs is to advance geroscience globally across the entire R&D value chain, by funding long-term basic research, accelerating the development of new drugs, expanding the therapeutic applications of existing drugs and ensuring that innovations in the field are accessible to everyone around the world,” commented Felipe Sierra, PhD, Scientific Director of the Hevolution Foundation.

“A fundamental part of this is supporting young researchers, and we are delighted to be working with AFAR on this new initiative.”

READ MORE: Launch of the Longevity Biotech Association

In addition, the Hevolution Foundation will establish a conference fund, managed by AFAR, to support scientific conferences and meetings on research in aging and geroscience.

Dr. Sierra concluded: “This collaboration with AFAR is the first of many agreements and partnerships that we hope to form with leading institutions and organizations in the field of aging and geroscience research worldwide. . With such funding, we intend to catalyze the field, enable its growth, and accelerate progress.

Recipients of the New Investigator Award will be chosen through a rigorous peer review process. Applications will be reviewed by established aging researchers who volunteer their time and expertise to select scientists and research projects most likely to make meaningful contributions to helping us stay healthy longer as we age. . AFAR and the Hevolution Foundation plan to announce the winners in the coming months.

For more information on the New Investigator Awards in Aging Biology and Geroscience, the Conference Fund, and all AFAR grant programs, please visit www.afar.org/funding-opportunities.


Register or log in to access our new investment portal and keep up to date with the latest investment news and trends.

Photography: Artem Podrez/Pexels, Hevolution Foundation